Science & Society

Rare Disease Diagnostics features in CSIR's top 10 innovations in 2018

posted Dec 26, 2018, 2:07 AM by Vinod Scaria

The Council of Scientific and Industrial Research has had an exciting 2018 where India’s first biofuel powered flight, aerospace technology, research in rare diseases, stroke, artificial intelligence and water disinfection have seen a major boost. Ranked 9th in the world, amongst a total of 1,207 government institutions, according to Scimago Institutions ranking, the institute has come a long way. These are ten exciting achievements which are going to take shape in the year 2019.

With 72,611,605 million Indians suffering from rare diseases there is a need for cost effective genetic tests which can be provided to the people. CSIR is working with a private company for licensing of 27 approved genetic tests which can be used commercially and will be launched in 2019.

https://www.deccanchronicle.com/nation/current-affairs/261218/csir-stands-tall-with-10-innovations-in-2018.html

CSIR-IGIB Partners with Genique for Genomic Applications in Rare Genetic Diseases

posted Dec 26, 2018, 1:57 AM by Vinod Scaria   [ updated Dec 26, 2018, 1:58 AM ]

Though rare genetic diseases are individually rare and encompass a spectrum of over 7000 diseases, together they amount to a significant number in the population. It is estimated that over 300 million people suffer from one or other rare genetic disease in the world. India shares a significant proportion of this, with estimates that it is home to over 30 million people with rare genetic diseases. Without a national programme for genetic diseases, and neonatal screening, many of the diseases remain undiagnosed. The diversity in social, cultural and marriage practices wuld also mean that many diseases run in families/communities, in some times significantly impairing the social function of the families, apart from the large economic and emotional burden these families/communities go through.

Addressing the problem of Genetic Diseases in India requires concerted efforts involving patients, clinicians researchers and industry.
CSIR IGIB signed an agreement with Genique Lifesciences to develop Genomics solutions for Genetic Diseases

CSIR-IGIB partners with Sanofi Genzyme in the area of Rare Genetic Diseases

posted Dec 26, 2018, 1:54 AM by Vinod Scaria   [ updated Dec 26, 2018, 1:55 AM ]

Though rare genetic diseases are individually rare and encompass a spectrum of over 7000 diseases, together they amount to a significant number in the population. It is estimated that over 300 million people suffer from one or other rare genetic disease in the world. India shares a significant proportion of this, with estimates that it is home to over 30 million people with rare genetic diseases. Without a national programme for genetic diseases, and neonatal screening, many of the diseases remain undiagnosed. The diversity in social, cultural and marriage practices would also mean that many diseases run in families/communities, in some times significantly impairing the social function of the families, apart from the large economic and emotional burden these families/communities go through.

In furtherence of SANOFI GENZME’s commitment to patients of rare diseases and the CSIR–INSTITUTE OF GENOMICS & INTEGRATIVE BIOLOGY‘s aim to initiate a unique research program on Genomics for understanding rare diseases, Sanofi Genzyme, a division of Sanofi-Synthelabo (India) Pvt. Limited hereby agrees to collaborate with the CSIR–INSTITUTE OF GENOMICS & INTEGRATIVE BIOLOGY for a partnership in the area of clinical genomics & rare genetic diseases.

1-3 of 3